| 英文名称 |
中文名称 |
CAS |
|
Mesylate pazufloxacin API
|
甲磺酸帕珠沙星原料药 |
|
|
Ziprasidone hydrochloride monohydrate
|
盐酸齐拉西酮一水合物 |
138982-67-9 |
|
Mirtazapine
|
米氮平 |
85650-52-8 |
|
1-(3-Hydroxymethylpyridin-2-yl)-4-methyl-2-phenylpiperazine
|
2-(4-甲基-2-苯基-1-哌嗪基)-3-吡啶甲醇 |
61337-89-1 |
|
Pamabrom
|
帕马溴 |
606-04-2 |
|
Pazufloxacin
|
帕珠沙星 |
127045-41-4 |
|
Bicalutamide intermediate
|
比卡鲁胺中间体 |
|
|
6-Chloro-5-(2-chloroethyl)oxindole
|
5-(2-氯乙基)-6-氯-1,3-二氢-吲哚-2-(2H)-酮 |
118289-55-7 |
|
2-(3-Carbethoxy-4-hydroxypyrrolidin-2-on-1-yl)ethyl acetate
|
2-(3-乙氧甲酰-4-羟基吡咯烷-2-酮-1-基)乙酸乙酯 |
62613-79-0 |
|
Lafutidine
|
拉呋替丁 |
118288-08-7 |
|
Leucoson
|
利可君 |
1950-36-3 |
|
3-Piperazinobenzisothiazole hydrochloride
|
3-(1-哌嗪基)-1,2-苯并异噻唑盐酸盐 |
144010-02-6 |
|
Ziprasidone mesilate
|
甲磺酸齐拉西酮 |
199191-69-0 |
|
p-Nitrophenyl 2-(Furfurylsulfinyl)acetate
|
alpha-(2-呋喃甲基亚磺酰基)乙酸-(4-硝基苯酚)酯 |
123855-55-0 |
|
Bicalutamide
|
比卡鲁胺 |
90357-06-5 |
|
Mirtazapine
|
米氮平 |
61337-67-5 |
|
N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)thio]-2-hydroxy-2-methylpropionamide
|
N-[4-氰基-3-(三氟甲基)苯基]-3-(4-氟苯巯基)-2-羟基-2-甲基丙酰胺 |
90356-78-8 |
|
N-[4-Cyano-3-(trifluoromethyl)phenyl]methacrylamide epoxide
|
N-[4-氰基-3-(三氟甲基)苯基]甲基环氧丙烯酰胺 |
90357-51-0 |
|
N-{4-[4-(Piperidinomethyl)pyridyl-2-oxy]-cis-2-butene}phthalimide maleic acid
|
N-[顺-4-[4-(N-哌啶甲基)吡啶-2-氧]-2-丁烯-1-基]邻苯二甲酰亚胺 顺丁烯二酸盐 |
146447-26-9 |
|
(Z)-4-[(Tetrahydro-2H-pyran-2-yl)oxy]-2-buten-1-ol
|
顺-4-(四氢吡喃-2-氧)-2-丁烯-1-醇 |
57323-06-5 |
|
A-(2-furylmethylsulfinyl)acetate-(4-nitrophenol) ester
|
A-(2-呋喃甲基亚磺酰基)乙酸-(4-硝基苯酚)酯 |
|
|
3-[(4-Fluorophenyl)thio]-2-hydroxy-2-methylpropanoic acid
|
3-(4-氟苯巯基)-2-羟基-2-甲基丙酸 |
339530-91-5 |
|
Cis-4-[4-(N-piperidinemethyl)pyridine-2-oxo-2-buten-1-amine
|
顺-4-[4-(N-哌啶甲基)吡啶-2-氧]-2-丁烯-1-胺 |
|
